RSS Content

Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference

BOULDER, Colo., Sept. 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Cantor Fitzgerald Global Healthcare Conference


Ron Squarer, Chief Executive Officer


Tuesday, September 26, 2017


8:35 a.m. Eastern Time


Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).


Tricia Haugeto

Array BioPharma Inc.



View original content with multimedia:

SOURCE Array BioPharma Inc.